Azithromycin and the microbiota of cystic fibrosis sputum

BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :BMC Microbiol
Главные авторы: Acosta, Nicole, Thornton, Christina S., Surette, Michael G., Somayaji, Ranjani, Rossi, Laura, Rabin, Harvey R., Parkins, Michael D.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2021
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/
https://ncbi.nlm.nih.gov/pubmed/33784986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы